are in fact the oldest adults, who are the ones who are most likely to end up in hospital to die. so, actually, the impact of the vaccine across europe has been enormous. and, similarly, that is the case today in australia, where the vaccine is recommended for older adults. in some parts, that s even been broadened because of the threat of the delta variant. so i don t feel disappointed. countries have to make their decisions based on the best evidence as they see it. but, in the end, i think the doses, the important thing is that doses get into people s arms, and particularly those at highest risk of disease. and i actually feel a sense of great pride that we ve got so many doses out there already, over the course of this year. and, professor pollard, i do not mean in any way to belittle the extraordinary scientific achievement that lies behind the oxford vaccine. but, nonetheless, would you acknowledge the truth
by reducing the risk of new variants arising in other countries. it also protects our economy, because if the whole world is opened up because they are no longer worried about the pressure on their health system, then that drives the global economy and it s good for all of us. there are so many reasons why our focus today should be on getting vaccines to those vulnerable in the rest of the world. to not do so is, i think, is an absolute tragedy for leadership. professor sir andrew pollard, i thank you very much forjoining me on hardtalk. thank you.